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Abstract 
Antibiotics play a pivotal role in modern medicine for the treatment of bacterial infection in patients. 
Membrane defines the boundary between single cell and its environment and is a main target for 
antibacterial agents. To better understand the mechanism of antibiotics action on microbes, we utilized 
liposome as membrane mimic model to study antibiotics interaction with bacterial membrane by variety of 
biophysical methods. Isothermal calorimetry and fluorescence photometry experiments were performed to 
examine interaction between antibiotics and liposome. We found that vancomycin, one of the most 
important antibiotics for the treatment of serious infections by gram-positive bacteria, binds to the 
liposome. The association between the drug and the liposome does not involve the tail part of the lipids. 
Moreover, the binding affinity increases along with the increment of liposome size. Of three major lipid 
components, phosphatidylglycerol is the preferential target for vancomycin binding. We also showed that 
vancomycin associates with vesicle derived from Staphylococcus aureus membrane in a similar manner as 
the binding to liposome. Our data suggested that vancomycin associates with bacterial membrane through 
direct interaction with lipid head groups with the extent of the association depending very much on specific 
type of lipids and curvature of local membrane structure. 
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Introduction 
Pathogenic bacteria pose a major threaten to public health, especially in under-developed region of the 
world. Large scale production and use of antibiotic penicillin during the World War II is a hallmark of 
modern antimicrobial therapy. Since then, a plethora of antimicrobial agents have been developed and 
commercialized, playing significant roles in improvement of human health, highlighted by gradual 
increasing of average life span worldwide. Prevailing of antibiotic treatment improves human health on 
one hand, but also triggers resistance of microbes to the drugs [1,2]. 
Depending on their structures and target sites within microorganism, different antibacterial drugs have 
distinct modes of action [3]. Of them, related to cell membrane are: inhibition or block of cell wall 
synthesis, inhibition of membrane protein or lipid synthesis and interference of cell membrane function. 
Some antibacterial peptides [4,5], peptidomimics [6] and small proteins [7] could interact with or insert 
into cell membrane, where they interfere membrane formation or alter local membrane structure, thus 
reducing bacteria growth or reproduction. Bacterial membrane is surrounded by a layer of peptidoglycan 
cell wall. This unique feature had rendered great interest in searching for glycopeptide and 
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lipoglycopeptide [8], which mimics bacterial cell wall synthesis substrates or binds to synthesis 
intermediates, thus inhibits cell wall synthesis, while having little effect on host cells. 
Glycopeptide antibiotic vancomycin has been used to treat a number of infections caused by broad 
spectrum of gram-positive bacteria [9,10]. It inhibits cell wall formation by binding to D-Ala-D-Ala terminus 
of peptidoglycan precursors and preventing them from cross-linking [11,12]. To cope with rising of 
antibiotic resistance including vancomycin, development of novel anti-bacterial agents with multiple action 
modes had been a promising strategy [13–15]. Herein, we studied the binding property of vancomycin to 
artificial and bacterial membranes using different biophysics methods with the aim to obtain a better 
understanding of the binding process for expanding its antibiotic repository. 
Experimental  
Materials  
1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (sodium salt) (POPG), 1-hexadecanoyl-2-(9Z-
octadecenoyl)-sn-glycero-3-phosphoethanolamine (POPE), 1-oleoyl-2-[12-[(7-nitro-2-1,3-benzoxadiazol-4-
yl)amino]dodecanoyl]-sn-glycero-3-phosphocholine (NBD PC) and cardiolipin (CL) were purchased from 
Avanti Polar Lipids. Vancomycin and nafcillin were obtained from Sigma. Lysozyme and RNaseA were 
purchased from Merck. Staphylococcus aureus was from ATCC (strain #43300) and cultured in tryptic soy 
broth medium (Becton, Dickinson and Company). Other chemicals were obtained from Sigma. 
Liposome preparation  
Lipids of known mass in chloroform were well-mixed, then dried at room temperature in a glass tube by 
continuous purging of high pure nitrogen gas. Being thoroughly dried in a speed vacuum, the lipids were re-
dissolved in phosphate buffer saline (PBS) buffer (10 mM Na2HPO4, 1.8 mM KH2PO4, 137 mM NaCl, 2.7 mM 
KCl, pH 7.4) pre-warmed over 45 °C. After repeated pipetting, the hydrated lipids were applied to a Lipex 
extruder (Northern Lipids Inc.) equipped with polycarbonate membrane for more than 10 times. Scattering 
profile of the liposome was then measured on a BI-200SM goniometer (Brookhaven Instruments) while 
being excited by a laser passing 637 nm filter with 100 micron pinhole from 90 degree angle at 25 °C. Data 
was collected and processed by the dynamic light scatter software coming with the equipment. 
Isolation of membrane from Staphylococcus aureus  
Isolation of membrane was carried out as described in the literature [16]. Briefly, bacteria were cultured 
till late exponential phase before harvest. Cells was then re-suspended in 50 mM potassium phosphate 
buffer, pH 8.0 and digested by lysozyme, deoxyribonuclease-1 and ribonuclease for 30 minutes in the 
presence of 10 mM MgSO4 at 37 °C. The reaction was stopped abruptly by 15 mM EDTA for 1 minute. 
Additional MgSO4 was then added to the system to bring its final concentration back to 10 mM. Digested 
cells was centrifuged at room temperature, 25000 g for 45 minutes to pellet the membrane, which was 
then re-suspended in PBS and applied through 18-g needle for more than 20 times. Resultant membrane 
vesicle was quantified by measuring protein concentration (Pierce™ BCA protein assay, Thermo Scientific), 
assuming equivalent amount of protein and lipid. Size distribution of the vesicles was assessed on a BI-
200SM goniometer as describe in previous section. 
Isothermal calorimetry measurement  
In a typical isothermal calorimetry (ITC) experiment carried out on a MicroCal iTC200 calorimeter 
(Malvern Instruments), 50 mM antibiotics were titrated into liposome with 5 mM lipid (total or individual) 
in PBS buffer at 25 °C. After each injection, system was allowed to regain thermal balance between sample 
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and reference chambers for 180 seconds with continuous stir of 750 rpm. Acquired data were processed by 
ITC-costumed Origin7 software using one-site model to avoid complication. Reference subtractions were 
performed against the data obtained by titrating antibiotic into PBS buffer. 
Fluorescence spectroscopy  
Spectra of the fluorescent lipid incorporated liposome were collected on an LS55 Fluorescence 
spectrometer (PerkinElmer) at room temperature.  Fluorescent spectra of freshly prepares 2-4 mM 
liposome containing 0.5 % NDB PC in PBS buffer was recorded in a cuvette. The sample was excited by 
xenon lamp centred at 485 nm with 2.5 nm slit width. A fraction of antibiotics with high concentration in 
PBS buffer was then introduced to minimize volume change. After mixed well, the spectrum of the sample 
was measured with the same setting. 
Results 
Vancomycin binds to liposome with a millimolar affinity.  
We first utilized liposome as membrane mimic to explore if vancomycin associates with the cell 
membrane at all. We performed isothermal calorimetry experiment by titrating antibiotics into liposome 
extruded through polycarbonate membrane (0.1 µm diameter). We found that vancomycin, but not β-
lactam antibiotic nafcillin, introduced significant amount of heat change in liposome prepared from a 
mixture of POPE, POPG and cardiolipin (CL) (75:20:5) (Figure 1), a model mimic for bacterial membrane 
[17]. Fitting of the data into one-site model gave rise to millimolar level affinity (dissociate constant, Kd), 
suggesting that vancomycin weakly, but definitely interact with liposome. The observation is in line with 
previous studies, where weak binding of vancomycin to model membrane were assessed by ITC [18] and 
surface plasmon resonance [19]. 
 
Figure 1. Titration of vancomycin into liposome. Raw data and fitting curve of ITC experiment (left); 
comparative fitting plot of naficillin and vancomycin titration with liposome (right). 
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Vancomycin binds to vesicle derived from Staphylococcus aureus membrane.  
Now that we showed vancomycin association with membrane mimic liposome, it is tempting to ask 
whether the antibiotic can also bind to vesicle derived from biological sample. We thus isolated membrane 
from gram-positive bacterium Staphylococcus aureus by means of enzymatic digestion, mechanical 
disruption and syringe needle homogenization [16]. Resultant vesicle was then undergone calorimetric 
titration with vancomycin as the titrant. According to the fitting result of ITC data, vancomycin also bound 
to the bacterial derived vesicle (Figure 2), but with much higher affinity (sub-millimolar) than that of 
liposome (Figure 2). Although we cannot completely rule out the possibility of residual peptidoglycan 
remaining on the membrane, lysozyme digestion step of the cells should remove most, if not all of them. 
Apparently, vancomycin binds to the bacterial membrane derived vesicle with higher affinity. 
 
Figure 2. Titration of vancomycin into vesicle derived from Staphylococcus aureus membrane. Raw data and 
fitting curve of ITC experiment (left); comparative fitting plot of vancomycin titration with liposome and 
vesicle from membrane (top right); size distribution of liposome and membrane vesicle determined by 
dynamic light scattering (bottom right). 
Vancomycin strengthens the association with liposome as its size increases.  
In light of differential binding between liposome and membrane-derived vesicle to vancomycin and the 
fact that the later measured much larger in diameter than the former (Figure 2), we speculated that the 
size of liposome/vesicle might play a role in the antibiotic association with membrane mimic. To test the 
hypothesis, we performed serial calorimetric titration of vancomycin into liposome prepared with 
polycarbonate membranes of various sizes (0.1, 0.4 and 1 µm). We found that the binding affinity of 
vancomycin increased along with liposome size increment. (Figure 3), which indicated that cell surface 
landscape or/and membrane curvature could be an important factor in vancomycin association. 
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Figure 3. Size-dependent binding of liposome with vancomycin. Data and fitting curve from titrations of 
liposome were plotted in same figure for comparison (left); Ka value derived from fitting were plotted against 
the sizes of the liposome (right). 
Vancomycin binds preferentially to POPG over cardiolipin and POPE.  
Because the lipids used in the study are similar structurally in fatty acid moiety but vary in head groups, 
we reasoned that their difference in head group could contribute differently to the association with 
vancomycin. To explore binding preference of vancomycin among lipids, we performed ITC measurement 
of the antibiotic with liposomes prepared from individual lipid. Based on the Ka value derived from data 
fitting, binding affinity of vancomycin to POPG is significantly higher than that to POPE and CL (Figure 4), 
suggesting that POPG is the major contributor to the association of vancomycin with liposome. The 
observation could be explained by careful examination of the structure of vancomycin [20,21] and the 
lipids (Figure 4). Positive charged amine in the head group of POPE does not appear to favour the 
interaction with uncharged vancomycin. Moreover, embedded hydroxyl group on hydrocarbon chain 
within two phosphoryl group is unlikely to facilitate binding in the case of cardiolipin. On the other hand, 
the two hydroxyls on the head group of the POPG could potentially interact with vancomycin via hydrogen 
bond formation, which promotes the glycopeptide association with lipid membrane [22]. 
Vancomycin interaction with liposome does not involve acyl terminus of the lipids.  
We have shown that vancomycin associates with liposome through its interaction with the head group 
of the lipids. But it remains unclear if the antibiotic could introduce any change inside the lipid bilayer. 
Fluorescence spectroscopy was performed to gain more insight into the binding of vancomycin to 
liposome. We incorporated trace amount (0.5 %) of tail fluorescence-labeled lipid (NDB-PC) into liposome. 
Addition of stoichiometric amount of vancomycin did not induce significant change in the spectrum of the 
liposome (Figure 5), suggesting that binding of vancomycin to liposome might not involve the acyl terminus 
of the lipid. In other words, it is unlikely for the antibiotic to insert deep into the lipids bilayer. Otherwise, 
alteration in fluorescence intensity or/and peak position shift would be obvious because of fluorophore 
disturbing by the insertion, as seen in a control experiment, where pore formation by depsipeptide 
antibiotics, valinomycin [23,24] reduced liposome fluorescence intensity substantially. This is consistent 
with the fact that vancomycin and other glycopeptides generally exhibit low membrane permeability 
[3,22]. 
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Figure 4. Vancomycin binds preferentially to POPG over POPE and cardiolipin. ITC raw data and fitting of 
vancomycin titration with POPG (top left), POPE (top right) and cardiolipin (bottom left); Fitting of titrations 
were plotted for comparison (middle left); Structure of three lipids were shown (bottom right). 
Discussion 
We have shown that glycopeptide antibiotics vancomycin associate with biomimetic membrane, a fact 
have been largely ignored in the field because of its weak interaction [18,19]. Furthermore, we showed for 
the first time that it binds to membrane vesicle derived from gram-positive bacteria Staphylococcus aureus 
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in a similar fashion. These observations could potentially open a new avenue for the prototype antibiotics 
to tackle infectious microbes by blocking cell wall synthesis and interfering cell membrane function 
simultaneously. Multiple mechanism of action is thought to be an effective strategy to combat with 
prevalent resistance nowadays rising among pathological microorganism [14,15,25]. 
 
Figure 5. Fluorescence spectra of liposome with fluorescent label. Left panel, spectra of 3.5 mM liposome 
containing 0.5 % NDB PC in the absence (green line) and presence (red line) of 5 mM vancomycin; right 
panel, spectra of 1.5 mM liposome containing 0.5 % NDB PC in the absence (green line) and presence (red 
line) of 2 mM valinomycin. 
We also found that vancomycin appears to bind to the membrane from outside and the extent of 
association depends much on local phospholipid composition and the curvature of the membrane. POPG 
appears to be the favourite target for vancomycin binding. Moreover larger size (flattened surface) of the 
liposome enhances the binding. These findings could provide some design ideas for further modification of 
the antibiotics to optimize its binding to bacterial membrane, which may improve antibacterial potency. To 
this end, a further investigation of vancomycin structure and bacterial membrane composition is required. 
In addition, self [20,21] and ligand-induced dimerization [26,27] of vancomycin might also play an 
important role as a larger hydrophobic interface once shielded by dimeric interaction has to be covered by 
membrane association. 
Conclusions 
We have studied the binding of vancomycin to biomimetic membranes based on three phospholipid 
components and bacterial membranes by using a variety of biophysical methods, including isothermal 
calorimetry and fluorescence photometry. It has been shown that the ways of association of vancomycin to 
biomimetic membranes is very similar to that of vesicle derived from Staphylococcus aureus membrane. 
Our results clearly indicated that vancomycin associates to the cell membrane from outside, and does not 
permeate through the cell membrane, which is consistent with the mechanisms of the drug action. By 
varying the size and composition of the biomimetic membrane vesicles, it has been demonstrated that the 
extent of association depends on specific type of lipids and curvature of local membrane structure. These 
observations could potentially open a new avenue to revive the prototype antibiotic to fight infectious 
microbe through the design of specific tight binders to the outer surface of bacterial membranes to impede 
cell wall synthesis. 
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